Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in biologic phenotype of human immunodeficiency virus during treatment of patients with didanosine.

The Journal of infectious diseases - 1 May 1996

Zheng N N, McQueen P W, Hurren L, Evans L A, Law M G, Forde S, Barker S, Cooper D A, Delaney S F

Abstract excerpt

Progression to AIDS in patients harboring human immunodeficiency virus type-1 (HIV-1) isolates expressing a syncytium-inducing (SI) phenotype is faster than in those in whom the virus expresses a non-SI (NSI) phenotype. Zidovudine monotherapy does not appear to alter this outcome. To examine the role of didanosine (ddI) monotherapy in phenotype expression, HIV-1 isolates from 73 patients receiving ddI for up to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Progression

Share to Giant Cells

Share to HIV Infections

Share to Leukocytes, Mononuclear

Share to Phenotype

Source

Identifiers

PMID: 8627059
DOI: 10.1093/infdis/173.5.1092

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes in biologic phenotype of human immunodeficiency virus during treatment of patients with didanosine.PMID 8627059Read ↗

Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis.Semantic proximity Read ↗

A cross-sectional comparison of persons with syncytium- and non-syncytium-inducing human immunodeficiency virus.Semantic proximity Read ↗

Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men.Semantic proximity Read ↗

Association of syncytium-inducing phenotype of HIV-1 with CD4 cell count, viral load and sociodemographic characteristics.Semantic proximity Read ↗

HIV-1 viraemia changes in patients with and without syncytium-inducing phenotype treated with nucleoside analogues: a case-control study.Semantic proximity Read ↗

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression.Semantic proximity Read ↗

Quantification of HIV-1 RNA during antiretroviral therapy: association with viral phenotype and development of resistance.Semantic proximity Read ↗

HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment.Semantic proximity Read ↗

Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection.Semantic proximity Read ↗

Emergence of syncytium-inducing human immunodeficiency virus type 1 variants coincides with a transient increase in viral RNA level and is an independent predictor for progression to AIDS.Semantic proximity Read ↗

T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy.Semantic proximity Read ↗

Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.